396 related articles for article (PubMed ID: 9263159)
1. Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus.
Stoll T; Gordon C; Seifert B; Richardson K; Malik J; Bacon PA; Isenberg DA
J Rheumatol; 1997 Aug; 24(8):1608-14. PubMed ID: 9263159
[TBL] [Abstract][Full Text] [Related]
2. Validation of the MOS SF-36 for quality of life assessment of patients with systemic lupus erythematosus in Singapore.
Thumboo J; Fong KY; Ng TP; Leong KH; Feng PH; Thio ST; Boey ML
J Rheumatol; 1999 Jan; 26(1):97-102. PubMed ID: 9918248
[TBL] [Abstract][Full Text] [Related]
3. The Rheumatology Attitudes Index and its helplessness subscale are valid and reliable measures of learned helplessness in Asian patients with systemic lupus erythematosus.
Thumboo J; Fong KY; Chan SP; Leong KH; Feng PH; Thio ST; Boey ML
J Rheumatol; 1999 Jul; 26(7):1512-7. PubMed ID: 10405938
[TBL] [Abstract][Full Text] [Related]
4. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study.
Mok CC; Ho LY; Cheung MY; Yu KL; To CH
Scand J Rheumatol; 2009; 38(2):121-7. PubMed ID: 18991189
[TBL] [Abstract][Full Text] [Related]
5. Health-related quality of life in portuguese SLE patients: an outcome measure independent of disease activity and cumulative damage.
Duarte C; Abreu P; Couto M; Vaz C; Malcata A; Inês L
Acta Reumatol Port; 2010; 35(1):30-5. PubMed ID: 20518146
[TBL] [Abstract][Full Text] [Related]
6. Fibromyalgia is a major contributor to quality of life in lupus.
Gladman DD; Urowitz MB; Gough J; MacKinnon A
J Rheumatol; 1997 Nov; 24(11):2145-8. PubMed ID: 9375874
[TBL] [Abstract][Full Text] [Related]
7. Can health utility measures be used in lupus research? A comparative validation and reliability study of 4 utility indices.
Moore AD; Clarke AE; Danoff DS; Joseph L; Bélisle P; Neville C; Fortin PR
J Rheumatol; 1999 Jun; 26(6):1285-90. PubMed ID: 10381044
[TBL] [Abstract][Full Text] [Related]
8. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance.
Hanly JG; McCurdy G; Fougere L; Douglas JA; Thompson K
J Rheumatol; 2004 Nov; 31(11):2156-62. PubMed ID: 15517627
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the quality of life of patients with systemic lupus erythematosus with and without endstage renal disease.
Vu TV; Escalante A
J Rheumatol; 1999 Dec; 26(12):2595-601. PubMed ID: 10606368
[TBL] [Abstract][Full Text] [Related]
10. Psychometric properties of the EuroQol-5D and Short Form-6D in patients with systemic lupus erythematosus.
Aggarwal R; Wilke CT; Pickard AS; Vats V; Mikolaitis R; Fogg L; Block JA; Jolly M
J Rheumatol; 2009 Jun; 36(6):1209-16. PubMed ID: 19369452
[TBL] [Abstract][Full Text] [Related]
11. Outcome measures to be used in clinical trials in systemic lupus erythematosus.
Strand V; Gladman D; Isenberg D; Petri M; Smolen J; Tugwell P
J Rheumatol; 1999 Feb; 26(2):490-7. PubMed ID: 9972993
[TBL] [Abstract][Full Text] [Related]
12. Cross-cultural validation of a disease-specific patient-reported outcome measure for systemic lupus erythematosus in Canada.
Bourré-Tessier J; Clarke AE; Mikolaitis-Preuss RA; Kosinski M; Bernatsky S; Block JA; Jolly M
J Rheumatol; 2013 Aug; 40(8):1327-33. PubMed ID: 23772082
[TBL] [Abstract][Full Text] [Related]
13. Determinants of health status in fibromyalgia: a comparative study with systemic lupus erythematosus.
Da Costa D; Dobkin PL; Fitzcharles MA; Fortin PR; Beaulieu A; Zummer M; Senécal JL; Goulet JR; Rich E; Choquette D; Clarke AE
J Rheumatol; 2000 Feb; 27(2):365-72. PubMed ID: 10685798
[TBL] [Abstract][Full Text] [Related]
14. Learning from discordance in patient and physician global assessments of systemic lupus erythematosus disease activity.
Neville C; Clarke AE; Joseph L; Belisle P; Ferland D; Fortin PR
J Rheumatol; 2000 Mar; 27(3):675-9. PubMed ID: 10743807
[TBL] [Abstract][Full Text] [Related]
15. Construct and criterion validity of the short form-6D utility measure in patients with systemic lupus erythematosus.
Harrison MJ; Ahmad Y; Haque S; Dale N; Teh LS; Snowden N; Ho P; Gorodkin R; Bruce IN
J Rheumatol; 2012 Apr; 39(4):735-42. PubMed ID: 22298908
[TBL] [Abstract][Full Text] [Related]
16. An exploration of patient-reported symptoms in systemic lupus erythematosus and the relationship to health-related quality of life.
Pettersson S; Lövgren M; Eriksson LE; Moberg C; Svenungsson E; Gunnarsson I; Welin Henriksson E
Scand J Rheumatol; 2012 Oct; 41(5):383-90. PubMed ID: 22646821
[TBL] [Abstract][Full Text] [Related]
17. SLICC/ACR Damage Index in Afro-Caribbean patients with systemic lupus erythematosus: changes in and relationship to disease activity, corticosteroid therapy, and prognosis.
Nossent JC
J Rheumatol; 1998 Apr; 25(4):654-9. PubMed ID: 9558165
[TBL] [Abstract][Full Text] [Related]
18. High predictive value of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for survival in systemic lupus erythematosus.
Nived O; Jönsen A; Bengtsson AA; Bengtsson C; Sturfelt G
J Rheumatol; 2002 Jul; 29(7):1398-400. PubMed ID: 12136895
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the relationship between disease activity and damage in patients with systemic lupus erythematosus--a 5-yr prospective study.
Stoll T; Sutcliffe N; Mach J; Klaghofer R; Isenberg DA
Rheumatology (Oxford); 2004 Aug; 43(8):1039-44. PubMed ID: 15161983
[TBL] [Abstract][Full Text] [Related]
20. How does quality of life of patients with systemic lupus erythematosus compare with that of other common chronic illnesses?
Jolly M
J Rheumatol; 2005 Sep; 32(9):1706-8. PubMed ID: 16142864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
